Schroder Investment Management Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-113,732
| Closed | -$11.2M | – | 1390 |
|
|
2019
Q3 | $11.2M | Buy |
113,732
+103,698
| +1,033% | +$9.85M | 0.02% | 591 |
|
|
2019
Q2 | $928K | Sell |
10,034
-164,820
| -94% | -$15.7M | ﹤0.01% | 924 |
|
|
2019
Q1 | $16.5M | Sell |
174,854
-194,712
| -53% | -$17M | 0.03% | 499 |
|
|
2018
Q4 | $23.7K | Buy |
369,566
+95,209
| +35% | +$7.03M | 0.04% | 397 |
|
|
2018
Q3 | $24.6M | Sell |
274,357
-333,234
| -55% | -$29.4M | 0.04% | 440 |
|
|
2018
Q2 | $46.6M | Sell |
607,591
-274,698
| -31% | -$22.8M | 0.08% | 282 |
|
|
2018
Q1 | $78.7M | Buy |
882,289
+635,516
| +258% | +$61M | 0.14% | 194 |
|
|
2017
Q4 | $25.8M | Sell |
246,773
-675,479
| -73% | -$76.2M | 0.04% | 448 |
|
|
2017
Q3 | $132M | Buy |
922,252
+413,453
| +81% | +$56.3M | 0.23% | 99 |
|
|
2017
Q2 | $67M | Buy |
508,799
+45,033
| +10% | +$5.52M | 0.12% | 219 |
|
|
2017
Q1 | $57.7M | Sell |
463,766
-168,717
| -27% | -$20.2M | 0.1% | 246 |
|
|
2016
Q4 | $73.2M | Sell |
632,483
-62,962
| -9% | -$7.01M | 0.14% | 194 |
|
|
2016
Q3 | $72.7M | Buy |
695,445
+230,259
| +49% | +$24.9M | 0.14% | 185 |
|
|
2016
Q2 | $45.9M | Sell |
465,186
-105,504
| -18% | -$10.9M | 0.09% | 282 |
|
|
2016
Q1 | $56.4M | Sell |
570,690
-329,059
| -37% | -$33.9M | 0.12% | 217 |
|
|
2015
Q4 | $108M | Sell |
899,749
-121,128
| -12% | -$14M | 0.22% | 111 |
|
|
2015
Q3 | $110M | Buy |
1,020,877
+186,697
| +22% | +$23.2M | 0.23% | 114 |
|
|
2015
Q2 | $95.9M | Buy |
834,180
+520,301
| +166% | +$59.5M | 0.19% | 132 |
|
|
2015
Q1 | $37.3M | Sell |
313,879
-234,282
| -43% | -$28M | 0.07% | 328 |
|
|
2014
Q4 | $61.3M | Buy |
548,161
+238,375
| +77% | +$25.1M | 0.12% | 219 |
|
|
2014
Q3 | $29.4M | Sell |
309,786
-17,828
| -5% | -$1.61M | 0.04% | 393 |
|
|
2014
Q2 | $28.1M | Buy |
327,614
+68,092
| +26% | +$5.18M | 0.03% | 403 |
|
|
2014
Q1 | $18.1M | Buy |
259,522
+52,090
| +25% | +$4.13M | 0.02% | 510 |
|
|
2013
Q4 | $17.5M | Buy |
207,432
+45,756
| +28% | +$3.62M | 0.02% | 517 |
|
|
2013
Q3 | $12.5M | Sell |
161,676
-261,424
| -62% | -$18.3M | 0.03% | 583 |
|
|
2013
Q2 | $24.7M | Buy |
+423,100
| New | +$25.5M | 0.07% | 355 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Schroder Investment Management Group's CELG Position: Q4 2019 in Review
Schroder Investment Management Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 113,732 shares — an estimated $11.2M sold.
Schroder Investment Management Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $132M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Schroder Investment Management Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Schroder Investment Management Group sold 113,732 Celgene Corp shares in Q4 2019, an estimated $11.2M.
- Schroder Investment Management Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Schroder Investment Management Group's Celgene Corp position peaked at $132M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Schroder Investment Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.